These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 15558450)
1. [Determination of sensitivity of biofilm-positive forms of microorganisms to antibiotics]. Holá V; Růzicka F; Tejkalová R; Votava M Klin Mikrobiol Infekc Lek; 2004 Oct; 10(5):218-22. PubMed ID: 15558450 [TBL] [Abstract][Full Text] [Related]
2. [Comparison of two different methods for the investigation of in vitro susceptibilities of planktonic and biofilm forming Candida species to antifungal agents]. Kaynak Onurdağ F; Ozgen S; Abbasoğlu U; Gürcan IS Mikrobiyol Bul; 2010 Oct; 44(4):619-31. PubMed ID: 21063974 [TBL] [Abstract][Full Text] [Related]
3. [Susceptibility of Staphylococcus aureus biofilms to vancomycin, gemtamicin and rifampin]. Kotulová D; Slobodníková L Epidemiol Mikrobiol Imunol; 2010 Apr; 59(2):80-7. PubMed ID: 20586169 [TBL] [Abstract][Full Text] [Related]
4. Application of a feasible method for determination of biofilm antimicrobial susceptibility in staphylococci. Antunes AL; Trentin DS; Bonfanti JW; Pinto CC; Perez LR; Macedo AJ; Barth AL APMIS; 2010 Nov; 118(11):873-7. PubMed ID: 20955460 [TBL] [Abstract][Full Text] [Related]
5. Minimal attachment killing (MAK): a versatile method for susceptibility testing of attached biofilm-positive and -negative Staphylococcus epidermidis. Knobloch JK; Von Osten H; Horstkotte MA; Rohde H; Mack D Med Microbiol Immunol; 2002 Oct; 191(2):107-14. PubMed ID: 12410350 [TBL] [Abstract][Full Text] [Related]
6. In vitro activity of ciprofloxacin, moxifloxacin, vancomycin and erythromycin against planktonic and biofilm forms of Corynebacterium urealyticum. Soriano F; Huelves L; Naves P; Rodríguez-Cerrato V; del Prado G; Ruiz V; Ponte C J Antimicrob Chemother; 2009 Feb; 63(2):353-6. PubMed ID: 19056748 [TBL] [Abstract][Full Text] [Related]
7. Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms. Sandoe JA; Wysome J; West AP; Heritage J; Wilcox MH J Antimicrob Chemother; 2006 Apr; 57(4):767-70. PubMed ID: 16464896 [TBL] [Abstract][Full Text] [Related]
8. Persister cells, the biofilm matrix and tolerance to metal cations in biofilm and planktonic Pseudomonas aeruginosa. Harrison JJ; Turner RJ; Ceri H Environ Microbiol; 2005 Jul; 7(7):981-94. PubMed ID: 15946294 [TBL] [Abstract][Full Text] [Related]
9. Synergy between protamine and vancomycin in the treatment of Staphylococcus epidermidis biofilms. Lee CK; Rubin LG; Moldwin RM Urology; 1995 Apr; 45(4):720-4. PubMed ID: 7716861 [TBL] [Abstract][Full Text] [Related]
10. High in vitro antimicrobial activity of synthetic antimicrobial peptidomimetics against staphylococcal biofilms. Flemming K; Klingenberg C; Cavanagh JP; Sletteng M; Stensen W; Svendsen JS; Flaegstad T J Antimicrob Chemother; 2009 Jan; 63(1):136-45. PubMed ID: 19010828 [TBL] [Abstract][Full Text] [Related]
11. Biofilm susceptibility to metal toxicity. Harrison JJ; Ceri H; Stremick CA; Turner RJ Environ Microbiol; 2004 Dec; 6(12):1220-7. PubMed ID: 15560820 [TBL] [Abstract][Full Text] [Related]
12. Telavancin: in vitro activity against staphylococci in a biofilm model. Gander S; Kinnaird A; Finch R J Antimicrob Chemother; 2005 Aug; 56(2):337-43. PubMed ID: 15972312 [TBL] [Abstract][Full Text] [Related]
13. In vitro activity of a new antibacterial rhodanine derivative against Staphylococcus epidermidis biofilms. Gualtieri M; Bastide L; Villain-Guillot P; Michaux-Charachon S; Latouche J; Leonetti JP J Antimicrob Chemother; 2006 Oct; 58(4):778-83. PubMed ID: 16880176 [TBL] [Abstract][Full Text] [Related]
14. [Differences in antibiotic sensitivity in biofilm-positive and biofilm-negative strains of Staphylococcus epidermidis isolated from blood cultures]. Holá V; Růzicka F; Votava M Epidemiol Mikrobiol Imunol; 2004; 53(2):66-9. PubMed ID: 15185631 [TBL] [Abstract][Full Text] [Related]
15. Densely adherent growth mode, rather than extracellular polymer substance matrix build-up ability, contributes to high resistance of Staphylococcus epidermidis biofilms to antibiotics. Qu Y; Daley AJ; Istivan TS; Rouch DA; Deighton MA J Antimicrob Chemother; 2010 Jul; 65(7):1405-11. PubMed ID: 20430788 [TBL] [Abstract][Full Text] [Related]
16. Biofilm eradication kinetics of the ultrashort lipopeptide C12 -OOWW-NH2 utilizing a modified MBEC Assay(™). Laverty G; Gorman SP; Gilmore BF Chem Biol Drug Des; 2015 May; 85(5):645-52. PubMed ID: 25264285 [TBL] [Abstract][Full Text] [Related]
17. In vitro activity of RBx 7644 (ranbezolid) on biofilm producing bacteria. Mathur T; Bhateja P; Pandya M; Fatma T; Rattan A Int J Antimicrob Agents; 2004 Oct; 24(4):369-73. PubMed ID: 15380263 [TBL] [Abstract][Full Text] [Related]
18. In vitro efficacy of ciprofloxacin and gentamicin against a biofilm of Pseudomonas aeruginosa and its free-living forms. Agarwal G; Kapil A; Kabra SK; Das BK; Dwivedi SN Natl Med J India; 2005; 18(4):184-6. PubMed ID: 16252547 [TBL] [Abstract][Full Text] [Related]
19. Effect of berberine on Staphylococcus epidermidis biofilm formation. Wang X; Yao X; Zhu Z; Tang T; Dai K; Sadovskaya I; Flahaut S; Jabbouri S Int J Antimicrob Agents; 2009 Jul; 34(1):60-6. PubMed ID: 19157797 [TBL] [Abstract][Full Text] [Related]